08Sep 2023
Amiloride evokes significant natriuresis and weight loss in kidney transplant recipients with and without albuminuria

Amiloride evokes significant natriuresis and weight loss in kidney transplant recipients with and without albuminuria

In a groundbreaking study, amiloride, an epithelial Na+ channel blocker, demonstrated significant potential in kidney transplant recipients (KTRs) for countering sodium retention and hypertension. The study, which included KTRs with and without albuminuria, revealed that amiloride led to a substantial increase in 24-hour urinary sodium excretion and decreased body weight in both groups. However, albuminuric KTRs experienced additional benefits, including decreased nocturnal systolic blood pressure and increased 24-hour urine aldosterone excretion. These findings suggest that epithelial Na+ channel blockers hold promise in optimizing blood pressure control in KTRs.

  • #nephrology

Like

Save

Share